Three different inhibitors of Na+,K+-ATPase (cardiac glycosides such as ouabain, oleandrin, and digoxin) inhibited the proliferation of human cancer cells (KB and HepG2 cells), and markedly decreased the expression levels of THADA, LAT1, and 4F2hc in the cells. The gene discussed is SLC3A2; the disease is cancer.